Currently, the Cancer and Leukemia Group B has a tool available for assessing the risks for men with prostate cancer. The CALGB Prostate Nomogram provides prostate cancer survival risk data at varying intervals, including 12-month, 18-month and 24-month. To access the nomogram, select the link below.

Prostate Cancer Nomogram